Chen H.-W.HUNG-YANG KUOBANG-BIN CHENYU-WEN TIENSUNG-HSIN KUOSHIH-HUNG YANG2020-02-202020-02-2020201554-7477https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079117928&doi=10.1200%2fJOP.19.00204&partnerID=40&md5=a7ee1ec41dbc65b3377cf63be09778d7https://scholars.lib.ntu.edu.tw/handle/123456789/461815[SDGs]SDG3alkaline phosphatase; cholesterol; gemcitabine; gimeracil plus oteracil potassium plus tegafur; glucose; hemoglobin A1c; high density lipoprotein cholesterol; triacylglycerol; oteracil; S 1 (combination); tegafur; adjuvant therapy; adult; alkaline phosphatase blood level; Article; blood examination; cancer recurrence; cancer staging; case report; cholesterol blood level; clinical article; computer assisted tomography; drug withdrawal; epigastric pain; fatty liver; female; glucose blood level; high density lipoprotein cholesterol level; human; hypercholesterolemia; hyperglycemia; hypertriglyceridemia; laboratory test; middle aged; pancreas adenocarcinoma; pancreaticoduodenectomy; triacylglycerol level; adenocarcinoma; blood; drug combination; hypertriglyceridemia; pancreas tumor; pathology; Adenocarcinoma; Drug Combinations; Female; Humans; Hypertriglyceridemia; Middle Aged; Oxonic Acid; Pancreatic Neoplasms; TegafurS-1–associated hypertriglyceridemia in a patient with pancreatic adenocarcinomajournal article10.1200/JOP.19.00204316180872-s2.0-85079117928